Last reviewed · How we verify
Glucose 5% (placebo)
Glucose 5% solution serves as an inert placebo control with no active pharmacological mechanism.
Glucose 5% solution serves as an inert placebo control with no active pharmacological mechanism. Used for Placebo control in phase 3 clinical trial (specific indication unknown).
At a glance
| Generic name | Glucose 5% (placebo) |
|---|---|
| Also known as | Placebo |
| Sponsor | Hospices Civils de Lyon |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a 5% dextrose solution in water, this preparation provides osmotic and nutritional support but is used in clinical trials as a control arm to establish baseline efficacy and safety of an investigational agent. The solution has no specific molecular target or therapeutic mechanism beyond basic fluid and caloric supplementation.
Approved indications
- Placebo control in phase 3 clinical trial (specific indication unknown)
Common side effects
- Hyperglycemia
- Phlebitis (if administered intravenously)
- Fluid overload
Key clinical trials
- Dexmedetomidine for Invasive Ventilation In the NEOnate (PHASE2, PHASE3)
- The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (PHASE4)
- A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer (PHASE2)
- Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease (EARLY_PHASE1)
- Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. (PHASE2)
- Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults (PHASE3)
- Safety of Sildenafil in Premature Infants (PHASE2)
- Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucose 5% (placebo) CI brief — competitive landscape report
- Glucose 5% (placebo) updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI